The one question that splits every hip pathway in two

Most patients arrive at the decision point with some version of the same question: is the damage bad enough that I need a new hip, or can the cartilage be repaired? It is a reasonable question, and — unusually in medicine — it has a reasonably clear answer, provided the right imaging has been done.

The decisive factor is not age, pain score, or how long symptoms have been present. It is the current state of the joint surface itself. When cartilage damage is focal — a defined area of loss in an otherwise intact joint, with the joint space still preserved — biological repair is often feasible. When damage has become diffuse and the bones are grinding against each other with no cartilage cushion remaining, there is no viable surface left for repair tissue to take hold. At that point, replacement of the joint becomes the appropriate pathway.

This distinction matters because cartilage repair tissue needs a mechanical foundation to survive. Place it into a bone-on-bone environment and the load of normal walking destroys it almost immediately. The biology cannot compensate for the structural reality.

Age is a strong secondary signal — preservation techniques are most commonly applied to patients under 45 to 50 — but it is not the primary gate. A 38-year-old with end-stage joint destruction may need replacement; a 55-year-old with a focal defect and preserved joint space may still be a preservation candidate. Specialist imaging and clinical assessment, not symptoms alone, draw that line.

Why hip cartilage cannot heal itself

Cartilage covering the femoral head and acetabulum contains no blood vessels within its substance. That absence of vasculature is why a cartilage injury in the hip triggers no meaningful healing response. When bone fractures, blood supply delivers the cells and chemical signals that initiate repair. When cartilage is damaged, nothing comparable occurs — the injury persists and, under the mechanical load of walking, typically deepens.

The hip carries the full body weight with every step, meaning even a small patch of cartilage loss concentrates stress on adjacent tissue in a way that accelerates further breakdown. Because cartilage also lacks nerve fibres, early focal lesions can be structurally significant while producing only vague or intermittent discomfort — the damage may progress for months or years before pain becomes consistent enough to prompt investigation.

This mismatch between structural state and symptom level is why imaging rather than pain intensity drives the treatment decision. Plain X-ray and MRI allow clinicians to grade cartilage loss using the Tönnis classification and to measure joint space width (JSW). A JSW above 3 mm and a Tönnis grade of 0 or 1 generally indicate that sufficient cartilage remains for a preservation approach to be viable. Once bone-on-bone contact appears on imaging — Tönnis grade 2 or 3 — there is no longer a stable surface for repair tissue to integrate into and mature, regardless of how symptoms present.

Who is a candidate for hip cartilage repair

Defect size and the quality of surrounding tissue are the two practical criteria any specialist will assess first. For marrow-stimulation approaches such as microfracture, evidence supports isolated lesions typically under 2 cm²; single-stage scaffold techniques such as AMIC extend that range for larger focal defects; and two-stage cell-based procedures — ACI and MACI — can address lesions up to around 10 cm² where the surrounding joint remains viable. All of these require preserved joint space and healthy cartilage beyond the defect boundary to give repair tissue a stable mechanical foundation.

Age informs the decision without controlling it. German epidemiological data across 116,179 hip cartilage procedures confirms that regenerative repair is predominantly performed on patients averaging 27.73 years; UK clinical guidance places the practical upper boundary around 45 to 50. Yet joint state weighs more heavily than the number itself — an older patient with a focal lesion in otherwise sound tissue may still qualify, and a younger patient with severe structural destruction may not.

Structural stability is a parallel factor clinicians will evaluate alongside cartilage grading. Labral tears, femoroacetabular impingement (FAI), and capsular laxity each alter the mechanical environment in which repair tissue must mature. Research confirms that preserving or restoring labral and capsular integrity significantly improves cartilage healing outcomes, with better defect filling and greater type II collagen expression compared with marrow stimulation in isolation. These structural conditions are therefore typically addressed before or simultaneously with the cartilage repair itself.

UK Non-Arthroplasty Hip Registry data — drawn from 9,845 patients — shows that both hip arthroscopy and periacetabular osteotomy produce clinically meaningful improvement in patient-reported scores within six months, reaching a plateau by two years. Age, BMI, and sex each influence recovery trajectories, so realistic expectations are shaped by the individual clinical picture rather than population averages alone.

Hip cartilage repair techniques and what each one addresses

Four broad technique categories exist, distinguished by invasiveness, the defect size they suit, and the type of tissue they produce.

Microfracture — historically used for isolated defects under 2 cm² — works by perforating the subchondral bone to draw marrow-derived progenitor cells into the lesion. The tissue that forms is fibrocartilage rather than native hyaline cartilage, and it is mechanically inferior. Controlled data confirm that around 20% of microfracture-only patients experience late deterioration by four years; the procedure also risks damaging the subchondral bone plate in ways that can limit future repair options. Its role has declined as single-stage alternatives with better biological outcomes have become available, and it should not be treated as a modern first choice.

AMIC (autologous matrix-induced chondrogenesis) combines the marrow-stimulation principle with a bio-collagen membrane placed over the defect in the same procedure. This single-stage approach handles larger focal lesions and provides a structured scaffold to support more organised tissue ingrowth than marrow stimulation alone.

ACI and MACI — autologous chondrocyte implantation and its matrix-seeded variant — address defects typically in the 2–10 cm² range. Chondrocytes are biopsied, laboratory-cultured, and re-implanted under a membrane in a second operation. The tissue produced is structurally closer to hyaline cartilage; long-term evidence in carefully selected candidates is robust, though the two-stage design and laboratory processing make this the most resource-intensive option on the pathway.

Osteochondral allograft (OCA) is used for larger or post-traumatic defects where autograft donor tissue is insufficient. Published series report 84.8% overall success at a mean follow-up of around 45 months. Graft preservation method is a significant variable: MOPS-processed tissue achieved 100% success in one series, compared with 50% using standard storage — a difference that substantially affects how outcomes are interpreted.

ChondroFiller injection is an acellular collagen scaffold delivered under ultrasound guidance as an outpatient procedure, requiring neither general anaesthetic nor operating theatre. Once placed, the scaffold acts as a matrix for matrix-induced chondrogenesis — recruiting the patient's own progenitor cells into the defect to support tissue regeneration. As with all repair approaches, the defect must meet size and cartilage-quality criteria for the biological environment to support repair; suitability is determined by imaging and specialist assessment.

When hip replacement becomes the right answer

Once the joint surface is comprehensively lost — cartilage gone across multiple zones, bone rubbing against bone — no repair technique has the mechanical foundation to succeed. At that stage, hip replacement is not a failure of preservation; it is the clinically appropriate answer at the right point in the pathway.

For Lincolnshire patients, that pathway runs through two practical channels. NHS total hip replacement is available locally through United Lincolnshire Hospitals NHS Trust. Private provision in Lincoln starts at around £14,218 through Circle Health Group. Both routes require prior failure of conservative care and imaging confirmation of end-stage disease before surgery is indicated.

Age does not confer immunity from this threshold. Younger patients with severe joint destruction caused by trauma, avascular necrosis, or inflammatory arthritis can reach bone-on-bone contact as surely as those with decades of cumulative osteoarthritis. The crossover criterion is joint state, not the patient's year of birth.

The SPAIRE technique (Save Piriformis And Internus, Repair Externus) is a modification of the traditional posterior approach that keeps the small rotator tendons at the back of the hip intact rather than cutting and reattaching them. Preserving this posterior soft-tissue envelope supports joint stability and removes the need for strict post-operative hip precautions. In a published series of 35 patients, mean time to orthotic-assisted walking was 1.5 days and Harris Hip Scores reached 83.16 at two months. These are short-term figures; longer follow-up data are not yet widely available, and individual outcomes depend on the clinical picture at the time of surgery. Lincolnshire Hip offers SPAIRE as part of its hip replacement pathway, with consultations in Grantham and Sleaford as well as remotely for patients across the region.

Getting assessed at the preservation crossroads in Lincolnshire

Deciding between cartilage repair and hip replacement cannot be resolved from symptoms or a GP consultation alone — the structural state of the joint surface is the determining factor, and that requires specialist imaging to establish.

A formal specialist assessment typically includes weight-bearing X-ray to evaluate joint space width and Tönnis grading, MRI to characterise cartilage thickness and lesion extent (quantitative cartilage sequencing can add further precision where available), clinical examination of hip range of motion, and a structured review of conservative care already attempted. Both NHS and private pathways in the UK require this evidence base before either surgical route is authorised.

NHS hip services in Lincolnshire run through United Lincolnshire Hospitals NHS Trust. For patients who prefer a private route — or who want an early specialist opinion without waiting for a GP referral — Lincolnshire Hip accepts patients directly, with consultations available in Grantham and Sleaford as well as remotely. Lincolnshire Hip is part of the MSK Doctors group.

The practical implication of everything covered here is that the preservation-versus-replacement question has a reliable answer — but only once the right clinical picture is in front of the right specialist. Given that untreated focal cartilage lesions deepen rather than stabilise, the value of that assessment lies not just in confirming which pathway fits, but in determining how much time remains to act on the preservable option.

1. [1] Evaluating a semiquantitative MRI-based scoring system (SHOMRI) to predict hip preservation or arthroplasty. (2025). https://doi.org/10.1093/jhps/hnaf027 https://doi.org/10.1093/jhps/hnaf027
2. [2] Sustained benefit of autologous matrix-induced chondrogenesis for hip cartilage repair in a recreational athletic population. (2019). https://doi.org/10.1007/s00167-019-05801-y https://doi.org/10.1007/s00167-019-05801-y
3. [3] Trends in Cartilage Repair Techniques for Chondral Defects in the Hip in Germany (2006–2022). (2024). https://doi.org/10.3390/life14101262 https://doi.org/10.3390/life14101262
4. [4] Preserving Hip Stability Yields Better Cartilage Repair With Microfracture Treatment. (2025). https://doi.org/10.1016/j.asmr.2025.101284 https://doi.org/10.1016/j.asmr.2025.101284